file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 1233, GCS 5398, CR 10163 Collection span: 1951 - 2011 | |
Word(i) List (1171) Word count: 3979, All words count: 6034 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
301 | CHARACTERIZATION | 9 | 6 | 18 |
302 | COMPOSITION | 1 | 6 | 70 |
303 | DAMAGE | 2 | 6 | 21 |
304 | EPIDEMIC | 2 | 6 | 25 |
305 | GENITAL | 2 | 6 | 18 |
306 | INTERPRETATIONS | 1 | 6 | 15 |
307 | MANIPULATION | 1 | 6 | 39 |
308 | MORPHOLOGY | 2 | 6 | 76 |
309 | PREPARATION | 1 | 6 | 12 |
310 | PREVENTABLE | 5 | 6 | 27 |
311 | RADIOACTIVE | 2 | 6 | 50 |
312 | RECOVERY | 2 | 6 | 21 |
313 | RESEARCH | 3 | 6 | 23 |
314 | RODENT | 1 | 6 | 39 |
315 | SPINA | 3 | 6 | 27 |
316 | TERATOLOGISTS | 2 | 6 | 8 |
317 | TESTICULAR | 1 | 6 | 10 |
318 | UNNECESSARY | 2 | 6 | 25 |
319 | VYS | 2 | 6 | 21 |
320 | ACELLULAR | 2 | 5 | 12 |
321 | ACETATE | 3 | 5 | 11 |
322 | ADDITION | 1 | 5 | 20 |
323 | ALPHA | 5 | 5 | 40 |
324 | ANTIKIDNEY | 1 | 5 | 6 |
325 | ASSOCIATION | 1 | 5 | 22 |
326 | BLEEDING | 1 | 5 | 22 |
327 | BLUE | 2 | 5 | 11 |
328 | C57B1 | 1 | 5 | 16 |
329 | C57BL | 1 | 5 | 11 |
330 | CAPROATE | 5 | 5 | 30 |
# | Word | Recs | TLCS | TGCS |
331 | CARCINOGENICITY | 1 | 5 | 18 |
332 | CHEMICALS | 4 | 5 | 41 |
333 | CHONDROCYTES | 1 | 5 | 11 |
334 | CHORIONIC | 1 | 5 | 22 |
335 | COMPLEX | 1 | 5 | 29 |
336 | CYTOSOLIC | 1 | 5 | 11 |
337 | DEFINITION | 1 | 5 | 18 |
338 | DILEMMA | 1 | 5 | 10 |
339 | EDITORS | 1 | 5 | 10 |
340 | ENRICHED | 1 | 5 | 20 |
341 | EPIPHYSEAL | 1 | 5 | 11 |
342 | ETIOLOGY | 6 | 5 | 8 |
343 | FLOUR | 1 | 5 | 20 |
344 | GENETIC | 2 | 5 | 29 |
345 | GENETICISTS | 1 | 5 | 7 |
346 | GESTATIONAL | 2 | 5 | 17 |
347 | HYDROXYPROGESTERONE | 5 | 5 | 30 |
348 | MEDROXYPROGESTERONE | 4 | 5 | 11 |
349 | METABOLISM | 3 | 5 | 11 |
350 | MODIFIED | 2 | 5 | 6 |
351 | MULTIPLICITY | 1 | 5 | 29 |
352 | NICHHD | 1 | 5 | 22 |
353 | OCCURRENCE | 3 | 5 | 22 |
354 | OFFSPRING | 3 | 5 | 17 |
355 | PEDIATRICIAN | 3 | 5 | 38 |
356 | PERSPECTIVES | 1 | 5 | 22 |
357 | POSITION | 3 | 5 | 145 |
358 | PROGESTATIONAL | 2 | 5 | 18 |
359 | PROGESTOGEN | 1 | 5 | 16 |
360 | PROVIDED | 1 | 5 | 22 |
# | Word | Recs | TLCS | TGCS |
361 | RADIONUCLIDES | 2 | 5 | 7 |
362 | RADIOSENSITIVITY | 1 | 5 | 16 |
363 | RECEPTOR | 5 | 5 | 15 |
364 | REPORTS | 1 | 5 | 10 |
365 | REQUIRE | 1 | 5 | 20 |
366 | REVIEWERS | 1 | 5 | 10 |
367 | SAMPLING | 1 | 5 | 22 |
368 | SOCIETY | 6 | 5 | 15 |
369 | STRUCTURALLY | 2 | 5 | 6 |
370 | SURVIVAL | 3 | 5 | 40 |
371 | THERAPY | 3 | 5 | 17 |
372 | TISSUES | 1 | 5 | 16 |
373 | TRYPAN | 2 | 5 | 11 |
374 | ULTRASTRUCTURE | 1 | 5 | 20 |
375 | UNIQUE | 2 | 5 | 72 |
376 | USE | 5 | 5 | 40 |
377 | VILLOUS | 1 | 5 | 22 |
378 | VITRO | 8 | 5 | 52 |
379 | WORKSHOP | 3 | 5 | 24 |
380 | 12TH | 2 | 4 | 26 |
381 | 19TH | 2 | 4 | 26 |
382 | AWARDS | 2 | 4 | 7 |
383 | BOUND | 2 | 4 | 4 |
384 | BRINGING | 2 | 4 | 13 |
385 | CAFFEINE | 2 | 4 | 43 |
386 | CARDIOVASCULAR | 1 | 4 | 6 |
387 | CELL | 4 | 4 | 39 |
388 | COLLAGEN | 3 | 4 | 228 |
389 | COMPLEXITIES | 1 | 4 | 14 |
390 | CONCENTRATION | 2 | 4 | 20 |
# | Word | Recs | TLCS | TGCS |
391 | COURTROOM | 4 | 4 | 15 |
392 | CULTURES | 4 | 4 | 229 |
393 | DAUBERT | 2 | 4 | 14 |
394 | DECISION | 2 | 4 | 14 |
395 | DEGRADATION | 2 | 4 | 5 |
396 | DISTORTION | 2 | 4 | 7 |
397 | EPIDEMIOLOGIC | 1 | 4 | 6 |
398 | FOCUSING | 3 | 4 | 4 |
399 | FREQUENTLY | 2 | 4 | 41 |
400 | IMPACT | 1 | 4 | 12 |
401 | IMPLANTATION | 3 | 4 | 44 |
402 | INFANT | 2 | 4 | 18 |
403 | INFANTILE | 1 | 4 | 36 |
404 | INFORMATION | 2 | 4 | 59 |
405 | ISOELECTRIC | 3 | 4 | 4 |
406 | JAUNDICE | 2 | 4 | 113 |
407 | MEDIATED | 2 | 4 | 11 |
408 | MEN | 3 | 4 | 57 |
409 | NONCOLLAGEN | 2 | 4 | 104 |
410 | NUTRITION | 2 | 4 | 17 |
411 | NUTRITIVE | 2 | 4 | 6 |
412 | PERIOD | 4 | 4 | 18 |
413 | PRESCRIBED | 2 | 4 | 41 |
414 | PROBLEM | 1 | 4 | 14 |
415 | PROCOLLAGEN | 6 | 4 | 150 |
416 | PROGRAM | 3 | 4 | 15 |
417 | PROPER | 1 | 4 | 6 |
418 | RADIOIODINE | 2 | 4 | 20 |
419 | REALITY | 2 | 4 | 7 |
420 | RECOGNITION | 2 | 4 | 7 |
# | Word | Recs | TLCS | TGCS |
421 | REFLEXES | 2 | 4 | 20 |
422 | RETARDING | 1 | 4 | 10 |
423 | SOLVING | 1 | 4 | 14 |
424 | SOURCE | 2 | 4 | 4 |
425 | STAGES | 3 | 4 | 50 |
426 | THYROID | 3 | 4 | 20 |
427 | UTILIZING | 2 | 4 | 6 |
428 | VIABILITY | 2 | 4 | 39 |
429 | VULNERABILITY | 4 | 4 | 23 |
430 | WOMEN | 8 | 4 | 70 |
431 | AGE | 5 | 3 | 27 |
432 | ALLEGATION | 1 | 3 | 16 |
433 | ANGIOTENSIN | 1 | 3 | 58 |
434 | ANIMAL | 9 | 3 | 67 |
435 | ARAVA | 1 | 3 | 44 |
436 | ARTICLE | 2 | 3 | 14 |
437 | BEHAVIORAL | 3 | 3 | 7 |
438 | BIOLOGICAL | 2 | 3 | 4 |
439 | BIOSYNTHESIS | 3 | 3 | 8 |
440 | CHAPTER | 1 | 3 | 16 |
441 | CHILDREN | 10 | 3 | 171 |
442 | CLASS | 1 | 3 | 58 |
443 | COMMENTARY | 2 | 3 | 14 |
444 | COMMENTS | 6 | 3 | 8 |
445 | CONTEMPLATING | 1 | 3 | 44 |
446 | CONTROVERSY | 4 | 3 | 7 |
447 | CONVERTING | 1 | 3 | 58 |
448 | COUNSELORS | 1 | 3 | 58 |
449 | DEMISE | 2 | 3 | 7 |
450 | DEPOSITION | 2 | 3 | 65 |